Top Story

Family history influenced risk for triple-negative breast cancer in women of Mexican descent

November 24, 2014

Women of Mexican descent diagnosed with breast cancer were twice as likely to present with triple-negative disease than other subtypes if they had a family history of breast or ovarian cancers, according to study results presented at the American Association for Cancer Research Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved in San Antonio.

“Triple-negative breast cancer is one of the worst breast cancer subtypes in terms of outcomes,” Maria Elena Martinez, PhD, Sam M. Walton endowed chair for cancer research and professor in the department of family and preventive medicine at the University of California, San Diego, Moores Cancer Center, said in a press release. “Our finding that family history is related to breast cancer subtype for Hispanic women of Mexican descent has tremendous implications for breast cancer treatment, screening and prevention among this population. It not only affects decisions around treatment plans for patients, but extends to screening and prevention plans for family members.”

William Maisel, MD, MPH FDA News

FDA warns against laparoscopic power morcellation for hysterectomy, myomectomy

November 24, 2014
The FDA today released an “immediately in effect” guidance that recommends laparoscopic power morcellators list a boxed warning and two contraindications on…
FDA News

FDA grants breakthrough therapy designation to JCAR015 for ALL

November 24, 2014
The FDA granted breakthrough therapy designation to JCAR015, a chimeric antigen receptor-modified T-cell therapy candidate, for the treatment of patients with…
Meeting News Coverage

Postoperative radiation extended survival in resected NSCLC

November 24, 2014
Postoperative radiotherapy improved survival by approximately 4 months in patients with resected non–small cell lung cancer with pathologically involved N2 lymph nodes…
Institution Notes

UC Davis appoints chair of department of public health sciences

November 23, 2014
Brad Pollock, PhD, MPH, has been named chair of the department of public health sciences at UC Davis School of Medicine. Pollock, whose research focuses on the incidence…
More News Headlines »
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »